Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From May 14, 2025

Krsnaa Diagnostics Q4 Results Review: Systematix Maintains 'Buy', Revises Target Price - Here's Why

Krsnaa Diagnostics Q4 Results Review: Systematix Maintains 'Buy', Revises Target Price - Here's Why
Krsnaa reported Q4 FY25 revenue of Rs 1,861 million, up 11.9% YoY and 6.6% QoQ. (Source: Unsplash)
STOCKS IN THIS STORY
Krsnaa Diagnostics Ltd
--

Krsnaa remains confident around a recovery of the receivables based on their ongoing interaction with officials. Krsnaa's track record on recovery of receivables so far remains clean with nothing lost on account of bad debts.

NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.

Systematix Report

Krsnaa Diagnostics Ltd.'s Q4 FY25 revenue (Rs 1,861 million) was below our and consensus expectations but Ebitda (Rs 530 million) was inline. Revenue growth was lackluster (12% YoY). The pathology to radiology mix for the quarter stood at 50:50 and D2C contribution was 3.5% of revenue. Krsnaa expects D2C contribution to expand meaningfully in FY26 (5-8% of revenue).

The radiology contribution is expected to increase as new centers open and ramp up. The revenue growth during the quarter was impacted by a slowdown in Himachal and Karnataka revenues owing to extended receivable days. Krsnaa remains confident around a recovery of the receivables based on their ongoing interaction with officials. Krsnaa's track record on recovery of receivables so far remains clean with nothing lost on account of bad debts.

We expect a ~20% revenue growth for Krsnaa for FY26 and FY27. Expansion in their D2C business and a resolution of receivable collection challenges should support business growth.

We revise our estimates lower, but maintain our Buy rating on Krsnaa with a revised target price of Rs 879 based on 23 times FY27E earnings per share.

Click on the attachment to read the full report:

DISCLAIMER

This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search